Veryan Medical Ltd.

Executive Summary

While the incorporation of drugs has radically reduced restenosis in coronary stents, it remains a serious issue in other vascular devices. Veryan Medical Ltd. thinks that the problem lies in the limitations of 2-D cylindrical devices to accommodate the natural, 3-D flow of blood. The company is building devices that replicate the swirling flow of blood through the vasculature. That spiral flow flushes out areas of stagnation and prevent the formation of intimal hyperplasia and restenosis.